P03 Administration of MF-300, an orally bioavailable small molecule inhibitor of 15-PGDH, demonstrates improved muscle force in preclinical models of neuromuscular dysfunction and disease
| Autor: | Webster, M., Vandermeulen, J., Martin, J., Fahr, B., Grant, V., Paulson, S., Clark, A., Khairallah, R. |
|---|---|
| Zdroj: | In Neuromuscular Disorders October 2023 33 Supplement 1:S162-S163 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect